March 6, 2015 – Oss, The Netherlands. ModiQuest Research BV, the Dutch antibody services company, today announced that it has entered into a collaboration with Cellectis aimed at the generation of novel monoclonal antibodies against Cellectis’ target(s). During the collaboration, ModiQuest may make use of its proprietary electrofusion technology, ModiFuseTM. Financial details of the collaboration … Continue reading